亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應格列苯脲

 
 
單價 1.00 / 千克對比
銷量 暫無
發貨 廣東深圳市付款后3天內
庫存 10000千克起訂1千克
品牌 南箭
型號 10238-21-8
規格 醫藥級 99%
過期 長期有效
更新 2013-05-09 15:25
 

深圳市石金谷科技有限公司藥業部

企業會員第13年
資料未認證
保證金未繳納
詳細說明

格列苯脲


中文名稱: 格列苯脲
中文同義詞: 格列本脲;N-[2-[4-[[[(環己氨基)羰基]氨基]磺?;鵠苯基]乙基]-2-甲氧基-5-氯苯甲酰胺;5-氯-N-[2-[4-[[[(環己基氨基)羰基]氨基]磺?;鵠苯基]乙基]-2-甲氧基苯甲酰胺;優降糖;格列呠咪;格列赫素;優降糖,99%
英文名稱: Glybenzcyclamide
英文同義詞: glybenclamide; glyburide usp; Glibenclamide; Glyburide; 5-chloro-n-(2-(4-((((cyclohexylamino)carbonyl)-amino)sulfonyl)phenyl)-ethyl)-2-methoxybenzamide; 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide; 5-chloro-2-methoxy-N-[2-[4-(phenylcarbamoylsulfamoyl)phenyl]ethyl]benzamide
CAS號: 10238-21-8
分子式: C23H28ClN3O5S
分子量: 494
EINECS號: 233-570-6
質量標準: EP6
包裝規格: 25公斤紙板桶
含量:醫藥級 99%
產品說明: 為白色結晶性粉末;幾乎無臭,無味。
用途:降血糖。適用于單用飲食控制療效不滿意的輕、中度Ⅱ型糖尿病,病人胰島β細胞有一定得分泌胰島素功能,并且無嚴重的并發癥。

舉報收藏 0評論 0
更多>本企業其它產品
廠家供應質優價廉利多卡因堿 米諾地爾(深圳) 供應大量莫西沙星側鏈 供應大量氫氯噻嗪 深圳廠家生產供應雙氯芬酸鈉 廠家供應奧美拉唑硫醚 廠家長期供應苯磺酸氨氯地平
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |